# Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System

> **NCT02120040** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 42 (estimated)

## Conditions studied

- Hemangioblastoma (HB) of the Central Nervous System (CNS)

## Interventions

- **OTHER:** evaluation of anxiety with psychosocial scales

## Key facts

- **NCT ID:** NCT02120040
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-02
- **Primary completion:** 2015-10-09
- **Final completion:** 2023-03-08
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120040, "Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02120040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*